Gritstone bio announces inducement grants under nasdaq listing rule 5635(c)(4)

Emeryville, calif., july 10, 2024 (globe newswire) -- gritstone bio, inc. (nasdaq: grts), a clinical-stage biotechnology company that aims to develop the world's most potent vaccines, today announced that the compensation committee of the company's board of directors granted one employee nonqualified stock options to purchase an aggregate of 39,000 shares of its common stock with an exercise price of $0.57, which is equal to the closing price of gritstone's common stock on july 3, 2024, the date of the grant. these stock options are part of an inducement material to the new employees becoming an employee of gritstone, in accordance with nasdaq listing rule 5635(c)(4).
NDAQ Ratings Summary
NDAQ Quant Ranking